Literature DB >> 26318874

B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2/6-VLP specific antibody responses and induce a Th17-like response after intrarectal immunization.

Fatou Thiam1, Annie Charpilienne2, Didier Poncet2, Evelyne Kohli1, Christelle Basset3.   

Abstract

The purpose of this study was to evaluate the adjuvant effect of the B subunits of cholera toxin (CT) and the thermolabile enterotoxin of Escherichia coli (LT) by the intrarectal route of immunization and compare them to the whole molecules CT and LT-R192G, a non toxic mutant of LT, using 2/6-VLP as an antigen, in mice. All molecules induced similar antigen specific antibody titers in serum and feces, whereas different T cell profiles were observed. CTB and LTB, conversely to CT and LT-R192G, did not induce detectable production of IL-2 by antigen specific T cells. Moreover, CTB, conversely to LT-R192G, CT and LTB, did not induce antigen specific CD4+CD25+Foxp3- and Foxp3+ T cells, thus showing different effects between the B subunits themselves. However, all molecules induced an antigen specific Th17 response. In conclusion, B subunits are potent adjuvants on B cell responses by the intrarectal route. Although their impact on T cell responses are different, all molecules induce a 2/6-VLP-specific Th17 T cell response that may play a major role in helping B cell responses and thus in adjuvanticity and protection.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B subunit; Cholera toxin; Immunization; Intrarectal; LT-R192G; Rotavirus

Mesh:

Substances:

Year:  2015        PMID: 26318874     DOI: 10.1016/j.micpath.2015.08.013

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

Review 1.  Adjuvant formulations for virus-like particle (VLP) based vaccines.

Authors:  Velasco Cimica; Jose M Galarza
Journal:  Clin Immunol       Date:  2017-08-03       Impact factor: 3.969

2.  E. coli Enterotoxin LtB Enhances Vaccine-Induced Anti-H. pylori Protection by Promoting Leukocyte Migration into Gastric Mucus via Inflammatory Lesions.

Authors:  Xiaoyan Peng; Rongguang Zhang; Chen Wang; Feiyan Yu; Mingyang Yu; Shuaiyin Chen; Qingtang Fan; Yuanlin Xi; Guangcai Duan
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

Review 3.  Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.

Authors:  Saghi Nooraei; Howra Bahrulolum; Zakieh Sadat Hoseini; Camellia Katalani; Abbas Hajizade; Andrew J Easton; Gholamreza Ahmadian
Journal:  J Nanobiotechnology       Date:  2021-02-25       Impact factor: 10.435

Review 4.  Adjuvants: friends in vaccine formulations against infectious diseases.

Authors:  G G Guerrero Manriquez; I Tuero
Journal:  Hum Vaccin Immunother       Date:  2021-07-21       Impact factor: 4.526

Review 5.  Review of Newly Identified Functions Associated With the Heat-Labile Toxin of Enterotoxigenic Escherichia coli.

Authors:  Qiangde Duan; Pengpeng Xia; Rahul Nandre; Weiping Zhang; Guoqiang Zhu
Journal:  Front Cell Infect Microbiol       Date:  2019-08-13       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.